Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CombiMatrix Introduces DNA Synthesizer for Microarrays.


NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG ACTG Acting
ACTG AIDS Clinical Trial Group
ACTG Actuating/Actuator
) announced today that its CombiMatrix group has launched the first CustomArray(TM) DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 Synthesizer synthesizer

Machine that electronically generates and modifies sounds, frequently with the use of a digital computer, for use in the composition of electronic music and in live performance.
, enabling researchers to build microarrays in their own facilities. For the first time, Pharmaceutical and Academic Core Facilities will have the ability to manufacture high quality commercial grade microarrays to their exact specifications with complete control over customization. This new system will allow researchers to fulfill their existing microarray requirements in addition to taking microarrays to new frontiers by exploring unique and novel applications.

"One of the biggest advantages of the CustomArray(TM) DNA Synthesizer, is the ability to fabricate commercial high quality arrays while having control over content and supply," said Michael Tognotti, Vice President of Sales and Marketing of CombiMatrix. "We have already shipped several machines and they are in use by customers at leading research organizations. We are very excited about this product and the large market it will serve."

The platform consists of the DNA CustomArray Synthesizer instrument and freely programmable microarrays or CustomArrays. Initially, the instrument has been designed to fabricate CombiMatrix's CustomArray12K (12,000 unique sites). The synthesizer will initially be marketed to the pharmaceutical, biotechnology, diagnostic, academic, and government sectors.

COMBIMATRIX CUSTOMARRAYS(TM)

CustomArrays are semiconductor-based arrays (approx. 1 cm2) integrated onto a standard 1" x 3" slide format. CustomArrays contain in situ In place. When something is "in situ," it is in its original location.  synthesized oligonucleotides, prepared using CombiMatrix's patented virtual-flask technology. Sensitivity and performance metrics Performance metrics are measures of an organizations activities and performance. Performance metrics should support a range of stakeholder needs from customers, shareholders to employees [1].  are available from the company's web site and at www.customarray.com.

ABOUT ACACIA RESEARCH COPORATION

Acacia Research Corporation comprises two operating groups: Acacia Technologies Group and CombiMatrix Group.

The CombiMatrix group is developing a platform technology to rapidly produce customizable arrays, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The CombiMatrix's group's technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology.

The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia controls 31 patent portfolios, which include over 120 U.S. patents, and certain foreign counterparts, covering technologies used in a wide variety of industries including audio/video enhancement & synchronization, broadcast data retrieval, computer memory cache coherency co·her·en·cy  
n. pl. co·her·en·cies
Coherence.

Noun 1. coherency - the state of cohering or sticking together
coherence, cohesion, cohesiveness
, credit card fraud Credit card fraud is a wide-ranging term for theft and fraud committed using a credit card or any similar payment mechanism as a fraudulent source of funds in a transaction. The purpose may be to obtain goods without paying, or to obtain unauthorized funds from an account.  protection, database management, data encryption & product activation, digital media transmission (DMT See DSL. (R)), digital video production, dynamic manufacturing modeling, enhanced Internet navigation, image resolution enhancement, interactive data sharing, interactive television, Internet access redirection, interstitial Internet advertising, laptop docking station connectivity, microprocessor enhancement, multi-dimensional bar codes, network data storage, resource scheduling, rotational video imaging and spreadsheet automation.

Acacia Research-Acacia Technologies (NASDAQ:ACTG) and Acacia Research-CombiMatrix (NASDAQ:CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.

Information about the Acacia Technologies Group and the CombiMatrix Group is available at www.acaciaresearch.com.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
, recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q

See 10-Q.
, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 9, 2005
Words:656
Previous Article:Northstream Becomes an inCode Wireless Company; World's Leading Pure Wireless Consultancy Adds European Strength And Focus.
Next Article:CVAS to Deploy Iview Technology to a Large Metropolitan Police Department in Michigan State.



Related Articles
Array of Hope for Gene Technology.
Acacia Research Subsidiary, CombiMatrix, Completes Major Milestone in Strategic Alliance with Roche.
CombiMatrix Corporation Completes Major Milestone in Strategic Alliance with Roche.
CombiMatrix Announces Sale of DNA Micorarray Synthesizer to Nihon Gene Research Laboratory.
CombiMatrix Announces Sale of DNA Micorarray Synthesizer to Keio University.
Use DNA technology to demystify pathogen.
CombiMatrix and Prisma Expand Relationship in China, Taiwan, and Other Countries.
CombiMatrix Announces Macrogen as Manufacturing/Distribution Partner in Korea and as Purchaser of Synthesizer Systems.
CombiMatrix and Furuno Launch DNA Microarray Synthesizer; New CE Marked Instrument Incorporates Reagents and Arrays in a Single Stand-Alone Unit.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles